Figure 2From: Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer Relapse-free survival (RFS) according to CCR6 and CCL19 expression. Panel A: relapse-free survival according to CCR6 expression in tumor cells. Panel B: relapse-free survival according to the presence of CCL19-expressing dendritic cells (DC).Back to article page